SIGA Technologies, Inc. (SIGA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $4.70. It has a SharesGrow Score of 79/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SIGA = $109.19 (+2223.2% from the current price, the stock appears undervalued).
Valuation: SIGA trades at a trailing Price-to-Earnings (P/E) of 13.6 (S&P 500 average ~25).
Financials: revenue is $95M, -2.1%/yr average growth. Net income is $23M, growing at +9%/yr. Net profit margin is 24.6% (strong). Gross margin is 68.6% (-1.6 pp trend).
Balance sheet: total debt is $595,169 against $199M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 11.83 (strong liquidity). Debt-to-assets is 0.3%. Total assets: $219M.
Analyst outlook: 1 / 1 analysts rate SIGA as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 85/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 46/100 (Partial), Future 100/100 (Pass), Income 85/100 (Pass).
